265 related articles for article (PubMed ID: 15372408)
21. In situ complement activation in porcine membranoproliferative glomerulonephritis type II.
Jansen JH; Høgåsen K; Harboe M; Hovig T
Kidney Int; 1998 Feb; 53(2):331-49. PubMed ID: 9461093
[TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
Iitaka K; Moriya S; Nakamura S; Tomonaga K; Sakai T
Pediatr Nephrol; 2002 May; 17(5):373-8. PubMed ID: 12042898
[TBL] [Abstract][Full Text] [Related]
23. IgG-associated primary glomerulonephritis in children.
Yoshikawa N; Iijima K; Shimomura M; Nakamura H; Ito H
Clin Nephrol; 1994 Nov; 42(5):281-7. PubMed ID: 7851027
[TBL] [Abstract][Full Text] [Related]
24. Early recurrence of dense deposit disease with marked endocapillary proliferation after renal transplantation.
Aita K; Ito S; Tanabe K; Toma H; Yamaguchi Y; Nagata M
Pathol Int; 2006 Feb; 56(2):101-9. PubMed ID: 16445823
[TBL] [Abstract][Full Text] [Related]
25. Membranoproliferative glomerulonephritis with unusual deposits of parallel arrangement striated structure: a new pathological entity?
.
Yahata K; Kikuchi Y; Koizumi M; Seta K; Wakui H; Komatsuda A; Shimizu A
Clin Nephrol; 2018 Feb; 89(2):123-129. PubMed ID: 29057733
[TBL] [Abstract][Full Text] [Related]
26. Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
Strife CF; McAdams AJ; West CD
Clin Nephrol; 1982 Jul; 18(1):9-16. PubMed ID: 6749363
[TBL] [Abstract][Full Text] [Related]
27. Composition of nephritic factor-generated glomerular deposits in membranoproliferative glomerulonephritis type 2.
West CD; Witte DP; McAdams AJ
Am J Kidney Dis; 2001 Jun; 37(6):1120-30. PubMed ID: 11382679
[TBL] [Abstract][Full Text] [Related]
28. Atypical membranoproliferative glomerulonephritis in a cat.
Inoue K; Kami-ie J; Ohtake S; Wakui S; Machida S; Shirota K
Vet Pathol; 2001 Jul; 38(4):468-70. PubMed ID: 11467485
[TBL] [Abstract][Full Text] [Related]
29. Familial membranoproliferative glomerulonephritis type III.
Neary J; Dorman A; Campbell E; Keogan M; Conlon P
Am J Kidney Dis; 2002 Jul; 40(1):E1. PubMed ID: 12087587
[TBL] [Abstract][Full Text] [Related]
30. [Clinical, laboratory and morphological characteristics of mesangioproliferative glomerulonephritis].
Tishkov I; Nedialkov A; Milkov V; Doĭchinov D; Minkova V
Vutr Boles; 1987; 26(5):91-5. PubMed ID: 3324489
[TBL] [Abstract][Full Text] [Related]
31. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.
Sethi S; Fervenza FC
Semin Nephrol; 2011 Jul; 31(4):341-8. PubMed ID: 21839367
[TBL] [Abstract][Full Text] [Related]
32. Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children.
Davis AE; Schneeberger EE; Grupe WE; McCluskey RT
Clin Nephrol; 1978 May; 9(5):184-93. PubMed ID: 657595
[TBL] [Abstract][Full Text] [Related]
33. Interstitial foam cells in renal biopsies: an aid in differentiating idiopathic membranoproliferative glomerulonephritis (type I) and membranoproliferative glomerulonephritis associated with systemic lupus erythematosus.
Poucell S; Thorner P; Balfe JW; Baumal R
Child Nephrol Urol; 1988-1989; 9(1-2):106-11. PubMed ID: 3251613
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporine therapy could be considered for membranoproliferative glomerulonephritis with immunoglobulin A deposits: a case report.
Hidaka Y; Tamura H; Furuie K; Kuraoka S; Nagata H; Nakazato H
BMC Nephrol; 2022 Nov; 23(1):358. PubMed ID: 36344919
[TBL] [Abstract][Full Text] [Related]
35. Histopathology of MPGN and C3 glomerulopathies.
Cook HT; Pickering MC
Nat Rev Nephrol; 2015 Jan; 11(1):14-22. PubMed ID: 25447133
[TBL] [Abstract][Full Text] [Related]
36. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.
Appel GB; Cook HT; Hageman G; Jennette JC; Kashgarian M; Kirschfink M; Lambris JD; Lanning L; Lutz HU; Meri S; Rose NR; Salant DJ; Sethi S; Smith RJ; Smoyer W; Tully HF; Tully SP; Walker P; Welsh M; Würzner R; Zipfel PF
J Am Soc Nephrol; 2005 May; 16(5):1392-403. PubMed ID: 15800116
[TBL] [Abstract][Full Text] [Related]
37. A paraneoplastic membranoproliferative glomerulonephritis with isolated C3 deposits associated with hairy cell leukaemia.
Abboud I; Galicier L; De Labarthe A; Dossier A; Glotz D; Verine J
Nephrol Dial Transplant; 2010 Jun; 25(6):2026-8. PubMed ID: 20335271
[TBL] [Abstract][Full Text] [Related]
38. [Electron microscopic structure of mesangioproliferative glomerulonephritis (MesPGN) in animals].
Drommer W; Jassim AM; Kaup FJ
Dtsch Tierarztl Wochenschr; 1989 Apr; 96(4):203-7. PubMed ID: 2653780
[TBL] [Abstract][Full Text] [Related]
39. Type 3 membranoproliferative glomerulonephritis: clinicopathologic correlations and long-term follow-up in nine patients.
Abreo K; Moorthy AV
Arch Pathol Lab Med; 1982 Aug; 106(8):413-7. PubMed ID: 6896632
[TBL] [Abstract][Full Text] [Related]
40. Management of membranoproliferative glomerulonephritis type II with plasmapheresis.
Kurtz KA; Schlueter AJ
J Clin Apher; 2002; 17(3):135-7. PubMed ID: 12378549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
